Français
ItalianoBond AbbVie 0% ( XS2117753603 ) in EUR
| Issuer | AbbVie | ||||||||
| Market price | 100.00 % ⇌ | ||||||||
| Country |  United States
|
||||||||
| ISIN code |
 XS2117753603 ( in EUR )
|
||||||||
| Interest rate | 0% | ||||||||
| Maturity | 15/11/2020 - Bond has expired | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | 100 000 EUR | ||||||||
| Total amount | 547 703 000 EUR | ||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The bond identified by ISIN XS2117753603, issued by AbbVie, a prominent global biopharmaceutical company headquartered in the United States renowned for its research-driven approach to developing advanced therapies across immunology, oncology, neuroscience, and virology, has successfully reached its maturity and been redeemed. This EUR-denominated security, a zero-coupon bond with no stated interest rate and a single payment frequency, originated from the United States with a total issuance size of 547,703,000 units and a minimum purchase size of 100,000 units, was observed at a market price of 100% prior to its maturity date of November 15, 2020. |
||||||||
| |||||||||